Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients

Medicine
Yuntao BingDianrong Xiu

Abstract

Protocadherin10 (PCDH10), a member of the nonclustered protocadherin family, functions as a tumor suppressor in many cancers. The aim of this study was to evaluate the expression level and prognostic value of PCDH10 in hepatocellular carcinoma (HCC) patients.Quantitative real-time polymerase chain reaction was used to analyze the expression level of PCDH10 in HCC tissues and adjacent nontumor tissues. The association of PCDH10 expression with clinicopathological features of patients was evaluated by chi-squared test. Overall survival was estimated using the Kaplan-Meier method. Besides, the patient prognosis was also evaluated by Cox regression analysis.PCDH10 expression was significantly lower in HCC tissues than that in adjacent nontumor tissues (P = .000). Kaplan-Meier curves showed that patients with lower PCDH10 expression had a worse overall survival. Moreover, PCDH10 expression level was associated tumor size (P = .005), tumor node metastasis stage (P = .002), smoking status (P = .000), and drinking status (P = .005). Multivariate analysis showed that the expression of PCDH10 (P = .000; hazard ratio = 4.784; 95% confidence interval: 2.550-8.977) was an independently associated with poor overall survival rates, as well as...Continue Reading

References

Jan 25, 2005·Journal of Hepatology·Jorge A MarreroAnna S Lok
Apr 1, 2005·Neoplasia : an International Journal for Oncology Research·Anke WahaAndreas Waha
Dec 22, 2010·Cell Adhesion & Migration·Soo-Young KimHyun Kim
Apr 5, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ju Dong YangLewis R Roberts
Oct 17, 2012·CA: a Cancer Journal for Clinicians·Oguz AkinHedvig Hricak
Oct 17, 2012·CA: a Cancer Journal for Clinicians·Mary Maluccio, Anne Covey
Nov 28, 2012·Journal of Cancer Research and Clinical Oncology·Xian ZhongShu Zheng
Aug 8, 2013·World Journal of Gastroenterology : WJG·Ho Joong ChoiYoung Kyoung You
Jun 29, 2014·Der Radiologe·M Güthle, M M Dollinger
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Jun 20, 2015·The Lancet Oncology·Alejandro Forner
Feb 18, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Qiu-Kui DengWen-Ping Li
Jan 1, 2014·Journal of Hepatocellular Carcinoma·Michael C Kew

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques

Software Mentioned

SPSS
GraphPad Prism

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.